Skip to main content
Funded Studies

Gerry Chillè, BFA

Chief Strategy and Innovation Officer at Newel Health

Location: Salerno Italy

Gerry Chillè is a co-founder and chief strategy and innovation officer of Newel Health, where he leads the research, development and commercial strategies of the company’s Digital Therapeutics (DTx) products pipeline. A frequent presenter at health innovation conferences and an advisor on committees that inform and steer the industry’s adoption of digital therapeutic solutions, Mr. Chillè is also a guest lecturer at Johns Hopkins University Carey School of Business. In these lectures, he covers emerging trends and industry dynamics of digital therapeutics and their impact on health economic models.

Associated Grants

  • Evaluation of a Digital Therapeutics (DTx) Mobile App and Algorithm for Personalized Medication and Treatment Plan Optimization for People with Parkinson’s Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.